Rofecoxib, selective COX-2 inhibitors and cardiovascular risk

被引：0
|
作者：
Dhaun, N. [1 ]
Maxwell, S. R. J. [1 ]
Webb, D. J. [2 ]
机构：
[1] Univ Edinburgh, Therapeut & Pharmacol, Edinburgh, Midlothian, Scotland
[2] Univ Edinburgh, Clin Pharmacol Unit, Edinburgh, Midlothian, Scotland
来源：
JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH | 2005年 / 35卷 / 02期
关键词：
Cardiovascular risk; Rofecoxib; selective COX-2 inhibitors;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：101 / 103
页数：3
相关论文
共 50 条
  • [1] Risk of cardiovascular events associated with selective COX-2 inhibitors
    Mukherjee, D
    Nissen, SE
    Topol, EJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (08): : 954 - 959
  • [2] COX-2 inhibitors and cardiovascular risk
    Funk, Colin D.
    FitzGerald, Garret A.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2007, 50 (05) : 470 - 479
  • [3] COX-2 Inhibitors and Cardiovascular Risk
    Cannon, Christopher P.
    Cannon, Paul J.
    SCIENCE, 2012, 336 (6087) : 1386 - 1387
  • [4] Rofecoxib: A selective COX-2 inhibitor
    不详
    Drugs & Therapy Perspectives, 2000, 15 (2) : 1 - 5
  • [5] Cox-2: where are we in 2003? - Cardiovascular risk and Cox-2 inhibitors
    Debabrata Mukherjee
    Eric J Topol
    Arthritis Res Ther, 5
  • [6] Rofecoxib: A selective and effective COX-2 inhibitor
    不详
    Drugs & Therapy Perspectives, 2002, 18 (2) : 1 - 3
  • [7] Selective COX-2 inhibition using Rofecoxib
    不详
    ORTHOPADE, 2000, 29 (02): : 1 - 4
  • [8] Tubulointerstitial nephritis associated with treatment with selective Cox-2 inhibitors, Celecoxib and Rofecoxib
    Ortiz, M
    Mon, C
    Fernández, MJ
    Sánchez, R
    Ude, FA
    Mampaso, F
    NEFROLOGIA, 2005, 25 (01): : 39 - 43
  • [9] Selective COX-2 inhibition and cardiovascular effects: A review of the rofecoxib development program
    Weir, MR
    Sperling, RS
    Reicin, A
    Gertz, BJ
    AMERICAN HEART JOURNAL, 2003, 146 (04) : 591 - 604
  • [10] Effects of the selective COX-2 inhibitors celecoxib and rofecoxib on human vascular cells
    Niederberger, E
    Manderscheid, C
    Grösch, S
    Schmidt, H
    Ehnert, C
    Geisslinger, G
    BIOCHEMICAL PHARMACOLOGY, 2004, 68 (02) : 341 - 350
12345